Rise In Infectious Diseases Fueling The Growth Of The Market Due To Increasing Transmission In Overcrowded Urban Areas Is Supporting Development Across The Norovirus Treatment Market

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Much Larger Will The Norovirus Treatment Market Become By 2030 Compared To 2026?

The norovirus treatment market size has expanded considerably in recent years. It is anticipated to increase from $1.94 billion in 2025 to $2.15 billion in 2026, progressing at a compound annual growth rate (CAGR) of 10.9%. The market’s historical expansion was shaped by elements such as restricted awareness of norovirus management, a reliance on treatments within hospitals, insufficient infrastructure for homecare, a lack of standardized protocols for symptom management, and a low uptake of probiotics and zinc supplementation.

The norovirus treatment market size is projected to experience substantial expansion over the upcoming years. By 2030, this market is anticipated to reach a valuation of $3.22 billion, exhibiting a compound annual growth rate (CAGR) of 10.6%. Key drivers for this growth during the forecast period include the increasing demand for oral rehydration solutions, the expansion of homecare services and telemedicine, a heightened focus on pediatric and elderly populations, the development of targeted supportive care therapies, and increases in healthcare expenditure and awareness campaigns. Significant trends expected during this period involve a greater embrace of oral rehydration therapies, increased administration of intravenous fluids for severe cases, the expansion of homecare and remote treatment modalities, broader utilization of anti-diarrheal and symptom management medications, and a specific focus on norovirus care for children and the elderly.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24629&type=smp

What Important Drivers Are Powering The Norovirus Treatment Market Growth?

The rising prevalence of infectious disease is projected to propel the growth of the norovirus treatment market going forward. These infectious diseases are illnesses caused by bacteria, viruses, fungi, or parasites that spread among people, including influenza, tuberculosis, HIV/AIDS, malaria, and norovirus. The rise in infectious diseases is linked to urban overcrowding, which facilitates the rapid transmission of pathogens within densely populated areas. Norovirus treatment helps alleviate the impact of infectious disease by effectively managing symptoms and limiting spread through appropriate hydration, hygiene, and isolation practices. For example, in March 2025, the World Health Organization, a Switzerland-based intergovernmental organization, reported that an estimated 10.8 million individuals, consisting of 6.0 million men, 3.6 million women, and 1.3 million children, contracted tuberculosis globally in 2023. Consequently, the increasing prevalence of infectious disease is driving growth of the norovirus treatment market.

How Is The Norovirus Treatment Market Structured Across Different Market Segments?

The norovirus treatment market covered in this report is segmented –

1) By Treatment: Electrolytes, Intravenous Fluids, Antipyretics, Analgesics, Anti-Diarrheal, Other Treatments

2) By Diagnosis: Bacteria Culture Test, Stool Tests, Other Diagnosis

3) By Route Of Administration: Oral, Intravenous

4) By End User: Hospitals, Clinics, Homecare Settings

Subsegments:

1) By Electrolytes: Oral Rehydration Salts (ORS), Sports Drinks, Pediatric Electrolyte Solutions

2) By Intravenous Fluids: Crystalloids, Colloids, Lactated Ringer’s Solution

3) By Antipyretics: Acetaminophen (Paracetamol), Ibuprofen, Aspirin

4) By Analgesics: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Opioid Analgesics, Acetaminophen-Based Analgesics

5) By Anti-Diarrheal: Loperamide, Bismuth Subsalicylate, Diphenoxylate-Atropine

6) By Other Treatments: Antiemetics, Probiotics, Zinc Supplements

What Trends Are Impacting The Norovirus Treatment Market?

Companies active in the norovirus treatment market are prioritizing the creation of innovative solutions, such as advanced mRNA vaccines, to accelerate the advancement of targeted immunization, enhance defense against severe infections, and alleviate the global burden of norovirus-related illnesses. Advanced mRNA vaccines are next-generation immunizations that utilize specially engineered messenger RNA to direct cells to produce specific proteins, thereby triggering a targeted immune response with improved stability, efficacy, and adaptability against various infectious diseases. For example, in October 2024, Moderna Inc., a US-based biotechnology company, partnered with the UK Health Security Agency (UKHSA), a UK-based government agency, to commence the world’s first Phase 3 trial of an mRNA norovirus vaccine (mRNA-1403) in the UK. This trial introduces a vaccine designed to target the highly contagious norovirus by instructing the body to produce viral proteins that stimulate a strong immune response without using the live virus. Noteworthy features of the launch include its application of stabilized mRNA for enhanced durability, rapid development potential in response to evolving strains, and its ability to elicit both antibody and T-cell responses.

Which Firms Are Competing In The Norovirus Treatment Market?

Major companies operating in the norovirus treatment market are Abbott Laboratories, Reckitt Benckiser Group plc, Nestlé Health Science, Otsuka Pharmaceutical Co. Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Limited, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Lupin Limited, Mylan (Viatris Inc.), Perrigo Company plc, Haleon plc, Church & Dwight Co. Inc., GlaxoSmithKline Consumer Healthcare, Sanofi Consumer Healthcare, Pfizer Consumer Healthcare, Ferring Pharmaceuticals, Fresenius Kabi AG, Baxter International Inc., B. Braun Melsungen AG, Hikma Pharmaceuticals PLC, Torrent Pharmaceuticals Ltd., Alkem Laboratories Ltd., Zydus Lifesciences Ltd., Glenmark Pharmaceuticals Ltd., Pfizer Healthcare India Pvt. Ltd., Mead Johnson Nutrition (Reckitt), Danone Nutricia, Amneal Pharmaceuticals Inc., Ajanta Pharma Ltd.

Access The Complete Norovirus Treatment Market Report:

https://www.thebusinessresearchcompany.com/report/norovirus-treatment-global-market-report

What Is The Largest Regional Market In The Norovirus Treatment Market?

North America was the largest region in the norovirus treatment market in 2025. The regions covered in the norovirus treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Norovirus Treatment Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=24629&type=smp

Browse Through More Reports Similar to the Global Norovirus Treatment Market 2026, By The Business Research Company

Nuclear Imaging Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/nuclear-imaging-devices-and-equipment-global-market-report

Nuclear Medicine Radioisotopes Market Report 2026

https://www.thebusinessresearchcompany.com/report/nuclear-medicine-radioisotopes-global-market-report

Nuclear Medicine Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/nuclear-medicine-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795